Sign up
Healthed-White-on-Blue

New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3

Description

In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ron Dick

A/Prof Ron Dick

Why is LDL control important?

Prof Carol Wham

Prof Carol Wham

Malnutrition and frailty in older adults - The importance of screening and early intervention

Prof Andrew Sindone

Prof Andrew Sindone

Heart failure and obesity - Which do we manage first?

Brett Lee

Brett Lee

The social media ban - Practical preparation for children and family

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

25 November 2025
Register Now
Prof Paul Van Buynder

expert

Prof Paul Van Buynder

Public Health Physician and Infectious Diseases Epidemiologist; Professor, School of Medicine, Griffith University, Queensland

Date published: 1 January 1970

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform